Redmile Group as of Dec. 31, 2022
Portfolio Holdings for Redmile Group
Redmile Group holds 69 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 10.1 | $247M | 20M | 12.21 | |
| Krystal Biotech (KRYS) | 6.1 | $150M | 1.9M | 79.22 | |
| Akero Therapeutics (AKRO) | 5.9 | $144M | 2.6M | 54.80 | |
| Replimune Group (REPL) | 5.4 | $131M | 4.8M | 27.20 | |
| Fate Therapeutics (FATE) | 5.3 | $131M | 13M | 10.09 | |
| Iveric Bio | 3.9 | $96M | 4.5M | 21.41 | |
| Xenon Pharmaceuticals (XENE) | 3.8 | $93M | 2.4M | 39.43 | |
| Celldex Therapeutics Com New (CLDX) | 3.6 | $88M | 2.0M | 44.57 | |
| Pliant Therapeutics (PLRX) | 3.1 | $75M | 3.9M | 19.33 | |
| Beam Therapeutics (BEAM) | 2.8 | $69M | 1.8M | 39.11 | |
| Kymera Therapeutics (KYMR) | 2.7 | $67M | 2.7M | 24.96 | |
| Livanova SHS (LIVN) | 2.5 | $61M | 1.1M | 55.54 | |
| Deciphera Pharmaceuticals | 2.4 | $59M | 3.6M | 16.39 | |
| Igm Biosciences (IGMS) | 2.3 | $57M | 3.3M | 17.01 | |
| Argenx Se Sponsored Adr (ARGX) | 2.3 | $56M | 149k | 378.83 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.1 | $51M | 319k | 159.31 | |
| Penumbra (PEN) | 2.0 | $49M | 222k | 222.46 | |
| Zymeworks Del (ZYME) | 2.0 | $49M | 6.2M | 7.86 | |
| Regenxbio Inc equity us cm (RGNX) | 1.8 | $43M | 1.9M | 22.68 | |
| ImmunoGen | 1.7 | $42M | 8.5M | 4.96 | |
| Prime Medicine (PRME) | 1.7 | $41M | 2.2M | 18.58 | |
| Repare Therapeutics Ord (RPTX) | 1.6 | $40M | 2.7M | 14.71 | |
| 1life Healthcare | 1.6 | $39M | 2.3M | 16.71 | |
| Nurix Therapeutics (NRIX) | 1.3 | $33M | 3.0M | 10.98 | |
| Oak Street Health | 1.2 | $31M | 1.4M | 21.51 | |
| Ventyx Biosciences (VTYX) | 1.2 | $29M | 895k | 32.79 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.2 | $29M | 7.6M | 3.84 | |
| Stryker Corporation (SYK) | 1.1 | $26M | 106k | 244.49 | |
| Entrada Therapeutics (TRDA) | 1.0 | $25M | 1.9M | 13.52 | |
| Gritstone Oncology Ord (GRTSQ) | 1.0 | $24M | 6.9M | 3.45 | |
| Verve Therapeutics (VERV) | 1.0 | $24M | 1.2M | 19.35 | |
| Centene Corporation (CNC) | 0.9 | $23M | 281k | 82.01 | |
| Augmedix (AUGX) | 0.9 | $22M | 14M | 1.56 | |
| Allakos | 0.9 | $21M | 2.5M | 8.42 | |
| Atara Biotherapeutics | 0.8 | $21M | 6.2M | 3.28 | |
| Anthem (ELV) | 0.8 | $20M | 39k | 512.97 | |
| Immunovant (IMVT) | 0.8 | $19M | 1.1M | 17.75 | |
| Scholar Rock Hldg Corp (SRRK) | 0.8 | $19M | 2.1M | 9.05 | |
| Annexon (ANNX) | 0.7 | $18M | 3.5M | 5.17 | |
| Stevanato Group S P A Ord Shs (STVN) | 0.7 | $17M | 943k | 17.97 | |
| Absci Corp (ABSI) | 0.7 | $17M | 8.0M | 2.10 | |
| Rapt Therapeutics | 0.6 | $16M | 785k | 19.80 | |
| Revolution Medicines (RVMD) | 0.6 | $15M | 625k | 23.82 | |
| Shattuck Labs (STTK) | 0.5 | $13M | 5.6M | 2.30 | |
| Medavail Holdings Ord | 0.4 | $10M | 35M | 0.30 | |
| Ionis Pharmaceuticals (IONS) | 0.4 | $10M | 266k | 37.77 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.4 | $9.9M | 2.8M | 3.50 | |
| Allovir (ALVR) | 0.4 | $9.8M | 1.9M | 5.13 | |
| Science 37 Holdings | 0.3 | $8.2M | 20M | 0.42 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $6.8M | 608k | 11.27 | |
| Stoke Therapeutics (STOK) | 0.2 | $5.9M | 642k | 9.23 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $5.8M | 3.0M | 1.92 | |
| Cabaletta Bio (CABA) | 0.2 | $4.3M | 464k | 9.25 | |
| Invitae (NVTAQ) | 0.2 | $4.2M | 2.3M | 1.86 | |
| Somalogic Class A Com | 0.2 | $3.8M | 1.5M | 2.51 | |
| Alpha Teknova (TKNO) | 0.1 | $3.1M | 558k | 5.64 | |
| Stereotaxis Com New (STXS) | 0.1 | $3.1M | 1.5M | 2.07 | |
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.1 | $2.8M | 326k | 8.50 | |
| Oncology Institu (TOI) | 0.1 | $2.6M | 1.6M | 1.65 | |
| Hookipa Pharma Inc equity | 0.1 | $2.5M | 3.1M | 0.81 | |
| Adagio Therapeutics (IVVD) | 0.1 | $2.2M | 1.4M | 1.50 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.4M | 1.6M | 0.90 | |
| Sonendo (SONX) | 0.1 | $1.4M | 498k | 2.83 | |
| Bioventus Com Cl A (BVS) | 0.1 | $1.4M | 536k | 2.61 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $1.4M | 1.0M | 1.33 | |
| Neoleukin Therapeutics | 0.0 | $942k | 1.9M | 0.51 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $731k | 731k | 1.00 | |
| Cytosorbents Corp Com New (CTSO) | 0.0 | $413k | 266k | 1.55 | |
| Atreca Cl A Com (BCEL) | 0.0 | $354k | 443k | 0.80 |